Synovus Financial — Q2 2023 Earnings Presentation
30 slides from Synovus Financial's earnings presentation, Jul 20, 2023
Slide 1: Second Quarter 2023 Results
Second Quarter 2023 Results Earnings Release July 20, 2023
Slide 2: Forward-Looking Statements
Forward-Looking Statements This slide presentation and certain of our other filings with the Securities and Exchange Commission contain statements that constitute "forward-looking statements" within the meaning of, and subject to the protections of, Section 27A of the Securities Act of 1933, as amen
Slide 3: Second Quarter 2023 Financial Highlights
Second Quarter 2023 Financial Highlights Key Highlights Key Performance Metrics Reported Adjusted(6) • PPNR(1) of $261 million, an 8% YoY increase Net Income Available to Common $165,819 $169,526 Shareholders(5) • Total revenue of $568 million, a 9% YoY increase ◦ Net interest income growth of 7% Yo
Slide 4: Total Loans $44.4 billion
Total Loans $44.4 billion Summary Diversified/High Quality Loan Portfolio • Total loan growth of $309 million QoQ; led by CRE growth, primarily the result of funding of existing multi-family commitments • C&I decline was driven by decline in line utilization (~$350 million impact) and exit of certai
Slide 5: Total Deposits $50.1 billion
Total Deposits $50.1 billion Summary QoQ Change in Ending Balances(3) • Total deposits increased $126 million ◦ Core deposit(1) decline of $155 million QoQ ($ in millions) (1) $1,248 ◦ Core deposits increased ~1% after the seasonal decline in April $625 $282 • Growth in Time deposits reflects contin
Slide 6: Net Interest Income $456 million
Net Interest Income $456 million Summary NII / NIM Trends • NII growth of $30 million or 7% YoY; QoQ decline of $25 million or 5% ($ in millions) • Benefits of higher asset yields and earning asset growth offset by continued $501 $478 $481 $456 increases in deposit costs and negative remixing of NIB
Slide 7: Non-Interest Revenue $112 million
Non-Interest Revenue $112 million Summary Fee Income • Overall core client fee income levels have been resilient, the result of stable revenue streams resulting from deep client relationships ($ in millions) 2Q23 QoQ Δ YoY Δ (1) • QoQ fee income decline primarily a result of exceptionally strong 1Q2
Slide 8: Non-Interest Expense $307 million
Non-Interest Expense $307 million Summary Expense Trends • YoY expense increase drivers include new initiative and infrastructure investments as well as investments in our workforce and FDIC/healthcare 2Q23 QoQ Δ YoY Δ ($ in millions) costs Total Employment $181 (3)% 10% • Continue to move forward w
Slide 9: Credit Quality
Credit Credit Quality Quality Summary 3-Year Credit Trends • Overall portfolio performance remains strong with net charge-offs of 0.24% in 4.10% 2Q and stable performance across broader portfolios and asset types 2.47% 2.22% 3.00% • CRE continues to perform well overall due to conservative underwrit
Slide 10: Capital
Capital Summary Capital Metrics • Organic earnings profile coupled with strategic management of balance sheet continuing to support capital accretion 12.43% 12.54% 12.72% 12.79% • Remain focused on building CET1 levels in light of current 10.56% 10.68% 10.81% 10.88% environment ◦ CET1 ended the quar
Slide 11: 2023 Updated Guidance
2023 Updated Guidance Prior Updated Guidance Guidance(1) Key Assumptions EoP Loan • Lower range impacted by planned Medical Office CRE sale of $1.3 billion 4 - 8% 0 - 2% • Loan production focused on core relationships Growth(2) EoP Core N/A 1 - 4% • Second-half seasonal benefits and new deposit init
Slide 12: Appendix
Appendix
Slide 13: Allowance for Credit Losses
Allowance for Credit Losses ($ in thousands) $19,204 $4,125 $526,968 $514,483 $(2,787) $(8,056) (1) 1Q23 Economic Forecast Net Growth Performance/Individual Other 2Q23 Impact Analysis ACL/ 1.17% 1.19% Loans: Economic Scenario Assumptions and Weightings 2Q23 2023(4) 2024(4) Scenario Model Weighting G
Slide 14: Earning Assets Composition
Earning Assets Composition ($ in millions) Loan Portfolio Rate Mix and Yield Total Securities Portfolio Size(1) 40% 40% 38% 37% 37% $11,014 $11,277 $11,273 $11,176 $11,174 5.89% 6.17% 5.36% 4.60% 3.92% 9% 8% 8% 8% 2.16% 2.16% 8% 2.09% 3% 3% 4% 6% 6% 1.93% 13% 18% 1.81% 25% 35% 42% 36% 31% 24% 15% 7%
Slide 15: Liquidity
Liquidity 2Q23 Deposit Walkdown Robust Contingent Sources of Liquidity ($ in billions, as of 6/30/23) ~87% of deposits insured, collateralized or insurable through our ICS capacity(1) compared to 75% in 1Q23 FRB Reserves, $1.4 $50.1 Fed Funds Lines, $1.7 (2) Third-Party Loans , $1.3 FHLB Borrowing $
Slide 16: Total Average Deposit Costs
Total Average Deposit Costs 1Q23 2Q23 June 2023 ($ in millions; rates annualized) Avg. Balance Avg. Rate Avg. Balance Avg. Rate Avg. Rate Non-interest-bearing $15,014 N/A $13,874 N/A N/A Interest-bearing non-maturity (NMD) $24,856 1.57% $24,636 2.08% 2.24% Time $3,601 2.42% $4,866 3.26% 3.47% Broker
Slide 17: Loan Portfolio by Category
Loan Portfolio by Category Consumer Portfolio - $8.5 billion CRE Portfolio - $13.3 billion • Weighted average credit score of 794 and 776 for Home Equity and • 92% are income-producing properties Mortgage, respectively • Diversity among property types and geographies • Weighted average LTV of 73% an
Slide 18: Commercial Real Estate
Commercial Real Estate Composition of 2Q23 CRE Portfolio Total Portfolio $13.3 billion Investment Properties portfolio represent 92% of total CRE portfolio 1.9% 0.7% 0.5% • The portfolio is well diversified among property types Office Building 1.5% • Credit quality in Investment Properties portfolio
Slide 19: Non-Medical Office Portfolio Analysis: $1.5B
Non-Medical Office Portfolio Analysis: $1.5B 2Q23 Key Credit Statistics: NPL Ratio: 1.86% NCO Ratio: 0.00% 90 DPD Ratio: 0.00% 2014 58.6% $8.7mm $3.4mm Top 5 MSAs: Current Balance Top 5 Loans and Current Average effective Average LTV(1) on Average size(1) of Median size(1) of Non-Med Office (mm) LTV
Slide 20: C&I Portfolio
C&I Portfolio Diverse Industry Exposure • Wholesale Bank (includes Large Corporate, Middle Market, Total C&I Portfolio $22.5 billion and Specialty Lines) represents 72% of C&I balances (1) Finance/Insurance 17.5% Senior Housing 15.5% • Finance/Insurance predominantly represented by secured lender fi
Slide 21: Consumer Portfolio
Consumer Portfolio Total Consumer Portfolio $8.5 billion Consumer Mortgage 63.1% • 84% of Consumer portfolio is backed by residential real estate Home Equity 20.8% • Other Consumer includes secured and unsecured products Third-Party HFI 9.5% • Average consumer card utilization rate is 25.8% • Third
Slide 22: Risk Distribution
Risk Distribution ($ in millions) Criticized & Classified Loans Portfolio Risk Distribution $1,568 Composition Change 2Q23 vs. $1,333 Risk Category 2Q23 1Q23 1Q23 $1,222 $1,086 Passing Grades $43,021 $42,959 $62 $1,028 $1,032 $914 $929 $942 4.1% Special Mention 543 369 174 3.2% 3.0% 2.6% 2.6% 2.5% S
Slide 23: Quarterly Highlights Trend
Quarterly Highlights Trend 2Q22 3Q22 4Q22 1Q23 2Q23 Diluted EPS $1.16 $1.33 $1.35 $1.32 $1.13 Net interest margin 3.22% 3.47% 3.56% 3.43% 3.20% Financial Efficiency ratio-TE 53.87% 50.41% 51.08% 52.33% 53.99% Performance Adjusted tangible efficiency ratio(1) 53.43% 49.98% 50.58% 50.48% 52.57% ROAA(2
Slide 24: Condensed Income Statement
Condensed Income Statement ($ in thousands, except per share data) 2Q23 1Q23 2Q22 Net interest income $455,531 $480,751 $425,388 Non-interest revenue 112,276 133,126 97,266 Non-interest expense 307,181 321,852 282,051 Provision for (reversal of) credit losses 38,881 32,154 12,688 Income before incom
Slide 25: Non-GAAP Financial Measures
Non-GAAP Financial Measures ($ in thousands, except per share data) 2Q23 1Q23 2Q22 Net income available to common shareholders $165,819 $193,868 $169,761 Recovery of NPA — (13,126) — Investment securities losses (gains), net — (1,030) — Loss (gain) on other loans held for sale 2,360 16,750 — Restruc
Slide 26: Non-GAAP Financial Measure, Continued
Non-GAAP Financial Measure, Continued ($ in thousands) 2Q22 3Q22 4Q22 1Q23 2Q23 Net income $178,052 $203,044 $205,770 $202,159 $173,944 Recovery of NPA — — — (13,126) — Loss (gain) on other loans held for sale — — — 16,750 2,360 Restructuring charges (reversals) (1,850) 956 (2,372) (733) (110) Valua
Slide 27: Non-GAAP Financial Measure, Continued
Non-GAAP Financial Measure, Continued ($ in thousands) 2Q23 1Q23 2Q22 Net income available to common shareholders $165,819 $193,868 $169,761 Recovery of NPA — (13,126) — Loss (gain) on other loans held for sale 2,360 16,750 — Restructuring charges (reversals) (110) (733) (1,850) Valuation adjustment
Slide 28: Non-GAAP Financial Measure, Continued
Non-GAAP Financial Measure, Continued ($ in thousands) 2Q22 3Q22 4Q22 1Q23 2Q23 Total non-interest revenue $97,266 $104,298 $102,439 $133,126 $112,276 Investment securities (gains) losses, net — — — (1,030) — Recovery of NPA — — — (13,126) — Fair value adjustment on non-qualified deferred compensati
Slide 29: Non-GAAP Financial Measure, Continued
Non-GAAP Financial Measure, Continued ($ in thousands) 2Q22 3Q22 4Q22 1Q23 2Q23 Adjusted non-interest expense $283,641 $294,130 $307,311 $304,464 $300,683 Amortization of intangibles (2,118) (2,118) (2,118) (1,857) (2,420) Adjusted tangible non-interest expense $281,523 $292,012 $305,193 $302,607 $2
Slide 30: Non-GAAP Financial Measure, Continued
Non-GAAP Financial Measure, Continued ($ in thousands) 2Q22 3Q22 4Q22 1Q23 2Q23 Total assets $57,382,745 $58,639,522 $59,731,378 $61,840,025 $60,655,591 Goodwill (452,390) (452,390) (452,390) (452,390) (475,573) Other intangible assets, net (31,360) (29,242) (27,124) (25,267) (61,538) Tangible asset